Grants per year
Personal profile
Research Interests
I am the PI on a phase 1 study "Suppression of allergic antibodies in human subjects" exploring a novel approach in people with allergies (allergic rhinitis) by injecting the neuropeptide, substance P. This work stems from a serendipitous observation in animals and then investigation of allergic subjects. The project is listed in clinicaltrials.gov. I am the PI on a study "Anti-TSLP plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy." This project is listed in clinicaltrials.gov.
Certifications and Licenses
| Internal Medicine | |
| Clinical & Laboratory Immunology | |
| Allergy & Immunology |
Training Experience
| 1974 | Internship, Methodist Hospital of Indiana |
| 1976 | Residency, Jewish Hospital of St. Louis |
| 1978 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MD, Indiana University
… → 1973
Research interests keywords
- Allergies
- Asthma
- Immunodeficiency
- Immunology
- Lungs / Breathing Problems
- Microbial Pathogenesis
Fingerprint
Dive into the research topics where Paul Allen Greenberger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 5 Finished
-
Prot# Q3662g: A Phase IIIb Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Xolair® in Subjects with Moderate to Severe Persistent Asthma Who are Inadequately Controlled with High-Dose Inhaled Corticosteroids & Long-Acting
Avila, P. C. & Greenberger, P. A.
Quintiles, Inc., Genentech, Inc.
7/18/06 → 10/18/10
Project: Research project
-
Clinical and Immunologic Analyses of Latex Reactions
Allegiance Healthcare Corporation
3/19/02 → 1/1/11
Project: Research project
-
Allergic Bronchopulmonary Aspergillosis, Allergic Fungal Sinusitis, and Hypersensitivity Pneumonitis
Greenberger, P. A., Jan 1 2023, Inflammatory Mechanisms in Allergic Diseases. CRC Press, p. 449-468 20 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Defining the Outcome Markers and Therapeutic Role for Omalizumab in Treatment of Allergic Bronchopulmonary Aspergillosis
Greenberger, P. A., Mar 2023, In: Journal of Allergy and Clinical Immunology: In Practice. 11, 3, p. 906-907 2 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial
Immune Tolerance Network ITN057AD CATNIP Study Team, Jan 2023, In: Journal of Allergy and Clinical Immunology. 151, 1, p. 192-201 10 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Intersection of Drug Allergy and Food Allergy
Greenberger, P. A., Jun 2023, In: Journal of Allergy and Clinical Immunology: In Practice. 11, 6, p. 1854-1855 2 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Minocycline-induced aseptic meningitis and drug reaction with eosinophilia and systemic symptoms
Kudlaty, E., Hamideh, N. & Greenberger, P. A., May 2023, In: Journal of Allergy and Clinical Immunology: In Practice. 11, 5, p. 1567-1569.e1Research output: Contribution to journal › Article › peer-review